
An AI model can accurately flag EGFR mutations in lung adenocarcinoma using routine pathology slides, reducing the need for rapid genetic tests.
Key Details
- 1Researchers from Mount Sinai, Memorial Sloan Kettering, and collaborators published results in Nature Medicine on July 9, 2025.
- 2The AI model predicts EGFR mutations from H&E-stained pathology slides of lung adenocarcinoma.
- 3A live 'silent trial' at Memorial Sloan Kettering showed the model could reduce rapid genetic testing by over 40%.
- 4The model was trained and validated on the largest multi-institutional dataset of matched slides and sequencing results from the US and Europe.
- 5Preserving tissue by avoiding unnecessary rapid tests allows for more comprehensive genomic sequencing.
- 6Work is ongoing to broaden the model's biomarker detection and deploy it in more healthcare settings.
Why It Matters

Source
EurekAlert
Related News

MRI Study Reveals Disease Epicenters Driving Atrophy in Multiple Sclerosis
Large-scale MRI analysis identifies specific brain regions acting as epicenters of atrophy in multiple sclerosis patients.

AI Now Drives Major Advances Across Scientific Fields, Report Finds
A comprehensive global analysis reveals AI as a cross-disciplinary engine, notably powering radiology and diagnostic innovations.

AI Combines CT and Pathology to Predict Esophageal Cancer Survival
A new AI framework (MENISA) combines CT scans, digital pathology, and tumor microenvironment data to predict survival risk for esophageal squamous cell carcinoma.